Compare · EAR vs HUM
EAR vs HUM
Side-by-side comparison of Eargo Inc. (EAR) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EAR and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $42.74B, about 239.2x EAR ($178.6M).
- HUM has hit the wire 4 times in the past 4 weeks while EAR has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 3 for EAR).
- Company
- Eargo Inc.
- Humana Inc.
- Price
- $2.57-2.28%
- $355.91+1.64%
- Market cap
- $178.6M
- $42.74B
- 1M return
- -
- +43.90%
- 1Y return
- -
- +52.72%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 4
- Recent ratings
- 3
- 25
Eargo Inc.
Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest EAR
- SEC Form 15-12G filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- Brownie William returned 296 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Narula Onkarr
- Wu David James returned 25,463 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Sabet-Peyman Afshin Justin
- SEC Form 4 filed by Bayne Katie J
- SEC Form 4 filed by Spence Donald J
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)